AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 99 filers reported holding AVROBIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $558,000 | -9.0% | 44,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $613,000 | -4.8% | 44,000 | -11.1% | 0.00% | -50.0% |
| Q3 2020 | $644,000 | -2.1% | 49,500 | +31.3% | 0.00% | 0.0% |
| Q2 2020 | $658,000 | +8.8% | 37,700 | -3.1% | 0.00% | 0.0% |
| Q1 2020 | $605,000 | +27.4% | 38,900 | +64.8% | 0.00% | +100.0% |
| Q4 2019 | $475,000 | +42.6% | 23,600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $333,000 | +10.6% | 23,600 | +27.6% | 0.00% | 0.0% |
| Q2 2019 | $301,000 | -8.0% | 18,500 | +193.7% | 0.00% | 0.0% |
| Q3 2018 | $327,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |